To do so, sEVs were purified from CCM from a CA-IX-overexpressing HEK293 cell line (HEK293-pRTS-CA9) and used as the target for a binding kinetic experiment with the selected antibody. This evidence concerns the gene CA9 and cerebral cavernous malformation.